Xenon Pharmaceuticals Inc
XP0
Company Profile
Business description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Contact
200-3650 Gilmore Way
BurnabyBCV5G 4W8
CANT: +1 604 484-3300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
370
Stocks News & Analysis
stocks
This former ASX tech darling is now 25% undervalued
Shares have fallen over 40% this year but revenue is still growing quickly.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,291.30 | 23.50 | 0.25% |
| CAC 40 | 8,306.03 | 27.44 | 0.33% |
| DAX 40 | 26,515.83 | 168.38 | 0.64% |
| Dow JONES (US) | 52,231.89 | 157.86 | -0.30% |
| FTSE 100 | 10,786.40 | 34.81 | 0.32% |
| HKSE | 24,315.92 | 241.12 | -0.98% |
| NASDAQ | 25,065.87 | 187.27 | -0.74% |
| Nikkei 225 | 61,248.59 | 789.01 | 1.31% |
| NZX 50 Index | 14,179.86 | 12.45 | 0.09% |
| S&P 500 | 7,520.93 | 29.01 | -0.38% |
| S&P/ASX 200 | 9,153.20 | 24.20 | 0.27% |
| SSE Composite Index | 3,680.64 | 16.92 | 0.46% |